Clovis More Than Halves on FDA Hurdle
Clovis Oncology was leading the bears in Monday’s trading session on news that its lung cancer drug may be delayed.
All Work
Chris Lange
Merck Prepares to Break Into HCV Market With Recent Study Results
Merck is joining the likes of Gilead Sciences in producing hepatitis C vaccines, but it is still in the early clinical stages.
Dillard’s Stumbles With Earnings Miss
Dillard's reported disappointing fiscal third-quarter financial results before the markets opened on Monday.
The Top 8 Earnings Previews for the Week Ahead
24/7 Wall St. again has put together a preview of some of the major companies reporting their quarterly results this week.
9 Companies That Destroyed Shareholders Last Week
After perhaps the best performance by the broad markets for the month of October in the past four years, this past week highlighted a few companies that missed their earnings, contrary to this earlier…
A Disaster of a Week for Retailers
This past week has been perhaps the worst week the markets have seen in months, and retail stocks were hit especially hard.
7 BioHealth Movers That Cannot Be Ignored
The biotech companies 24/7 Wall St. has picked stood out from the rest with incredible gains or losses over the course of the past week.
The 4 Stocks That Helped Push the Dow Even Lower on Friday
November 13, 2015: Markets opened lower across the board on Friday after having originally been indicated marginally lower, over the course of the day they managed to make Friday the biggest loss of the…
Alcobra Gears Up for Secondary Offering
Alcobra has announced the pricing of its underwritten secondary offering for more than 6 million shares.
Hutchison China MediTech Files for IPO
Hutchison China MediTech has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Instructure Quietly Enters the Market in IPO
Instructure quietly entered the market on Friday in its initial public offering, with more than $4 million shares priced at the bottom end of the expected price range.
How Analysts Are Treating Cisco After Earnings and Guidance
After Cisco Systems reported its fiscal firs- quarter earnings, a few key analysts have weigh in on what could have possibly gone wrong.
Fossil Stumbles Over Weak Guidance
Fossil Group released its third-quarter earnings report and announced an acquisition after the markets closed on Thursday.
JC Penney Earnings Are Not Enough for Investors
J.C. Penney Co. Inc. (NYSE: JCP) reported better-than-expected fiscal third-quarter financial results before the markets opened on Friday.
The 4 Stocks That Held Down the Dow Jones Industrial Average
November 11, 2015: Markets opened up on Wednesday but over the course of the day the markets drifted lower to close the day marginally negative. The dollar gained only slightly while equities traded sideways…
The Numbers Behind Alibaba’s Singles Day
Singles Day was originally established as an "anti-Valentine's Day," where singles, rather than couples, would purchase each other gifts or even just gifts for themselves.
What to Expect From El Pollo Loco Earnings
El Pollo Loco is scheduled to report its third-quarter financial results on Thursday after the markets close.
Why Key Analyst Sees Activision Blizzard Rising 20%
Argus maintained a Buy rating for Activision Blizzard and raised its price target to $41, implying upside of 18%.
Wave Life Sciences Sneaks Into the Market With IPO
Wave Life Sciences PTE entered the market Wednesday morning in its initial public offering (IPO).
SurgiQuest Files for IPO
SurgiQuest has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).